A detailed history of De Burlo Group Inc transactions in Amgen Inc stock. As of the latest transaction made, De Burlo Group Inc holds 1,095 shares of AMGN stock, worth $362,762. This represents 0.04% of its overall portfolio holdings.

Number of Shares
1,095
Previous 1,145 4.37%
Holding current value
$362,762
Previous $329,000 5.47%
% of portfolio
0.04%
Previous 0.05%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 13, 2024

SELL
$268.87 - $324.56 $13,443 - $16,228
-50 Reduced 4.37%
1,095 $311,000
Q4 2022

Feb 14, 2023

BUY
$229.03 - $291.01 $249,642 - $317,200
1,090 Added 1981.82%
1,145 $300,000
Q3 2022

Nov 14, 2022

SELL
$224.46 - $253.15 $185,628 - $209,355
-827 Reduced 93.76%
55 $12,000
Q2 2022

Aug 11, 2022

BUY
$230.71 - $256.74 $190,797 - $212,323
827 Added 1503.64%
882 $215,000
Q1 2022

May 16, 2022

BUY
$219.27 - $242.57 $12,059 - $13,341
55 New
55 $13,000

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $177B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track De Burlo Group Inc Portfolio

Follow De Burlo Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of De Burlo Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on De Burlo Group Inc with notifications on news.